Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase…
Biotechnology
US, Cardiff-by-the-Sea [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Viracta Therapeutics, Inc. (VIRX) to it's peer group.
Peer Group
CABA TARA XFOR TRVI LPTX RLYB TCON TNYA GLUE TERN BMEA INZY ALXO IGMS LYRA EYPT STOK VINC SQZ
Compare Together
Loading...